CEL-SCI Corporation logo
CEL-SCI Corporation CVM
$ 3.88 -8.92%

Quarterly report 2025-Q4
added 02-17-2026

report update icon

CEL-SCI Corporation Gross Profit 2011-2026 | CVM

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
  • Raw materials and supplies
  • Wages of production personnel
  • Depreciation of equipment
  • Transportation and warehousing costs (if directly related to production)
Importance for business:
  • Assessing core business profitability
    If gross profit is declining, it may indicate rising production costs or falling sales.
  • Financial planning
    Gross profit is the basis for calculating other key metrics, such as operating and net profit.
  • Benchmarking against competitors
    Gross profit analysis helps compare the efficiency of different companies within the same industry.
  • Insights into pricing effectiveness
    If gross profit is low, the company may be pricing too low or failing to control costs effectively.
Reasons for a decline in gross profit:
  • Increase in raw material and supply costs
  • Rising production expenses
  • Price reductions due to competition
  • Decrease in sales volume
  • Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit CEL-SCI Corporation

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - - - - - - - - - 255 K 956 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
956 K 255 K 605 K

Gross Profit of other stocks in the Biotechnology industry

Issuer Gross Profit Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
180 M - 2.43 % $ 254 M germanyGermany
Acer Therapeutics Acer Therapeutics
ACER
1.27 M - 2.71 % $ 14 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
0.006 $ 3.34 0.45 % $ 3.9 M usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.52 B - - $ 40.3 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
102 K - -10.17 % $ 12.2 K usaUSA
Codexis Codexis
CDXS
52.8 M $ 1.02 1.49 % $ 74.9 M usaUSA
Cerus Corporation Cerus Corporation
CERS
60.4 M $ 2.6 1.37 % $ 480 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
12.1 - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
-428 K - -18.52 % $ 27.3 M britainBritain
Cellectis S.A. Cellectis S.A.
CLLS
37.7 M $ 3.87 -0.39 % $ 116 M franceFrance
Acorda Therapeutics Acorda Therapeutics
ACOR
119 M - -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
-32.3 K - 4.01 % $ 150 M canadaCanada
Adverum Biotechnologies Adverum Biotechnologies
ADVM
2.32 M - - $ 86.2 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
774 M - - - russiaRussia
AIkido Pharma AIkido Pharma
AIKI
10 K - 1.93 % $ 17.4 M usaUSA
Collegium Pharmaceutical Collegium Pharmaceutical
COLL
128 M $ 41.75 0.19 % $ 1.32 B usaUSA
Albireo Pharma Albireo Pharma
ALBO
39.2 M - -0.23 % $ 916 M usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
301 M $ 36.14 1.23 % $ 3.75 B usaUSA
Amarin Corporation plc Amarin Corporation plc
AMRN
166 M $ 13.98 1.27 % $ 5.7 B irlandaIrlanda
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
87.5 M $ 23.77 2.99 % $ 2.91 B usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
3.94 M $ 8.41 -1.87 % $ 36.4 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
245 K $ 1.94 0.01 % $ 130 M usaUSA
Curis Curis
CRIS
9.5 M $ 1.1 -3.51 % $ 6.94 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
4.73 M - 5.93 % $ 314 M canadaCanada
CorMedix CorMedix
CRMD
61.7 K $ 7.16 0.42 % $ 364 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-523 K - -11.43 % $ 502 K usaUSA
Champions Oncology Champions Oncology
CSBR
12.8 M $ 6.14 3.89 % $ 83.9 M usaUSA
Aravive Aravive
ARAV
5.68 K - -13.39 % $ 1.45 M usaUSA
Aptinyx Aptinyx
APTX
1.56 K - -39.0 % $ 4.57 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
1 K - 17.91 % $ 11.1 M usaUSA
Altimmune Altimmune
ALT
8.18 K $ 4.21 -2.32 % $ 299 M usaUSA